Global Respiratory Syncytial Virus Vaccines Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Respiratory Syncytial Virus Vaccines Industry Forecast” looks at past sales and reviews total world Respiratory Syncytial Virus Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Respiratory Syncytial Virus Vaccines sales for 2023 through 2029. With Respiratory Syncytial Virus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Syncytial Virus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Syncytial Virus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Syncytial Virus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Syncytial Virus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Syncytial Virus Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Syncytial Virus Vaccines.
The global Respiratory Syncytial Virus Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Respiratory Syncytial Virus Vaccines players cover Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus Vaccines market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Respiratory Syncytial Virus Vaccines Industry Forecast” looks at past sales and reviews total world Respiratory Syncytial Virus Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Respiratory Syncytial Virus Vaccines sales for 2023 through 2029. With Respiratory Syncytial Virus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Syncytial Virus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Respiratory Syncytial Virus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Syncytial Virus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Syncytial Virus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Syncytial Virus Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Syncytial Virus Vaccines.
The global Respiratory Syncytial Virus Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Respiratory Syncytial Virus Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Respiratory Syncytial Virus Vaccines players cover Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus Vaccines market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Palivizumab
- RSVpreF PF06928316
- RSVPreF3 OA (GSK3844766A)
- mRNA-1345
- Janssen RSV Vaccine
- ResVax
- Nirsevimab (MEDI8897)
- MVA-BN RSV
- Hospital
- Clinic
- Research Institute
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.Pfizer Inc.
- Sanofi
- Merck Sharp & Dohme
- GlaxoSmithKline
- SOBI
- Johnson & Johnson
- Bavarian Nordic
- Novavax
- AstraZeneca
- Moderna
- Codagenix
- Intravacc
- Alphavax
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Syncytial Virus Vaccines Market Size 2018-2029
2.1.2 Respiratory Syncytial Virus Vaccines Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Respiratory Syncytial Virus Vaccines Segment by Type
2.2.1 Palivizumab
2.2.2 RSVpreF PF06928316
2.2.3 RSVPreF3 OA (GSK3844766A)
2.2.4 mRNA-1345
2.2.5 Janssen RSV Vaccine
2.2.6 ResVax
2.2.7 Nirsevimab (MEDI8897)
2.2.8 MVA-BN RSV
2.3 Respiratory Syncytial Virus Vaccines Market Size by Type
2.3.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
2.4 Respiratory Syncytial Virus Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.5 Respiratory Syncytial Virus Vaccines Market Size by Application
2.5.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
3 RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET SIZE BY PLAYER
3.1 Respiratory Syncytial Virus Vaccines Market Size Market Share by Players
3.1.1 Global Respiratory Syncytial Virus Vaccines Revenue by Players (2018-2023)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RESPIRATORY SYNCYTIAL VIRUS VACCINES BY REGIONS
4.1 Respiratory Syncytial Virus Vaccines Market Size by Regions (2018-2023)
4.2 Americas Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.3 APAC Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.4 Europe Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023)
5.2 Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
5.3 Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023)
6.2 APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
6.3 APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Respiratory Syncytial Virus Vaccines by Country (2018-2023)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Syncytial Virus Vaccines by Region (2018-2023)
8.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
8.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET FORECAST
10.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2024-2029)
10.1.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2024-2029)
10.1.2 Americas Respiratory Syncytial Virus Vaccines Forecast
10.1.3 APAC Respiratory Syncytial Virus Vaccines Forecast
10.1.4 Europe Respiratory Syncytial Virus Vaccines Forecast
10.1.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast
10.2 Americas Respiratory Syncytial Virus Vaccines Forecast by Country (2024-2029)
10.2.1 United States Respiratory Syncytial Virus Vaccines Market Forecast
10.2.2 Canada Respiratory Syncytial Virus Vaccines Market Forecast
10.2.3 Mexico Respiratory Syncytial Virus Vaccines Market Forecast
10.2.4 Brazil Respiratory Syncytial Virus Vaccines Market Forecast
10.3 APAC Respiratory Syncytial Virus Vaccines Forecast by Region (2024-2029)
10.3.1 China Respiratory Syncytial Virus Vaccines Market Forecast
10.3.2 Japan Respiratory Syncytial Virus Vaccines Market Forecast
10.3.3 Korea Respiratory Syncytial Virus Vaccines Market Forecast
10.3.4 Southeast Asia Respiratory Syncytial Virus Vaccines Market Forecast
10.3.5 India Respiratory Syncytial Virus Vaccines Market Forecast
10.3.6 Australia Respiratory Syncytial Virus Vaccines Market Forecast
10.4 Europe Respiratory Syncytial Virus Vaccines Forecast by Country (2024-2029)
10.4.1 Germany Respiratory Syncytial Virus Vaccines Market Forecast
10.4.2 France Respiratory Syncytial Virus Vaccines Market Forecast
10.4.3 UK Respiratory Syncytial Virus Vaccines Market Forecast
10.4.4 Italy Respiratory Syncytial Virus Vaccines Market Forecast
10.4.5 Russia Respiratory Syncytial Virus Vaccines Market Forecast
10.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast by Region (2024-2029)
10.5.1 Egypt Respiratory Syncytial Virus Vaccines Market Forecast
10.5.2 South Africa Respiratory Syncytial Virus Vaccines Market Forecast
10.5.3 Israel Respiratory Syncytial Virus Vaccines Market Forecast
10.5.4 Turkey Respiratory Syncytial Virus Vaccines Market Forecast
10.5.5 GCC Countries Respiratory Syncytial Virus Vaccines Market Forecast
10.6 Global Respiratory Syncytial Virus Vaccines Forecast by Type (2024-2029)
10.7 Global Respiratory Syncytial Virus Vaccines Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Information
11.1.2 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Inc.Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc.Pfizer Inc. Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Respiratory Syncytial Virus Vaccines Product Offered
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Information
11.3.2 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Merck Sharp & Dohme Main Business Overview
11.3.5 Merck Sharp & Dohme Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 SOBI
11.5.1 SOBI Company Information
11.5.2 SOBI Respiratory Syncytial Virus Vaccines Product Offered
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 SOBI Main Business Overview
11.5.5 SOBI Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Information
11.7.2 Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bavarian Nordic Main Business Overview
11.7.5 Bavarian Nordic Latest Developments
11.8 Novavax
11.8.1 Novavax Company Information
11.8.2 Novavax Respiratory Syncytial Virus Vaccines Product Offered
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novavax Main Business Overview
11.8.5 Novavax Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Moderna
11.10.1 Moderna Company Information
11.10.2 Moderna Respiratory Syncytial Virus Vaccines Product Offered
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Moderna Main Business Overview
11.10.5 Moderna Latest Developments
11.11 Codagenix
11.11.1 Codagenix Company Information
11.11.2 Codagenix Respiratory Syncytial Virus Vaccines Product Offered
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Codagenix Main Business Overview
11.11.5 Codagenix Latest Developments
11.12 Intravacc
11.12.1 Intravacc Company Information
11.12.2 Intravacc Respiratory Syncytial Virus Vaccines Product Offered
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Intravacc Main Business Overview
11.12.5 Intravacc Latest Developments
11.13 Alphavax
11.13.1 Alphavax Company Information
11.13.2 Alphavax Respiratory Syncytial Virus Vaccines Product Offered
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Alphavax Main Business Overview
11.13.5 Alphavax Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Respiratory Syncytial Virus Vaccines Market Size 2018-2029
2.1.2 Respiratory Syncytial Virus Vaccines Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Respiratory Syncytial Virus Vaccines Segment by Type
2.2.1 Palivizumab
2.2.2 RSVpreF PF06928316
2.2.3 RSVPreF3 OA (GSK3844766A)
2.2.4 mRNA-1345
2.2.5 Janssen RSV Vaccine
2.2.6 ResVax
2.2.7 Nirsevimab (MEDI8897)
2.2.8 MVA-BN RSV
2.3 Respiratory Syncytial Virus Vaccines Market Size by Type
2.3.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
2.4 Respiratory Syncytial Virus Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.5 Respiratory Syncytial Virus Vaccines Market Size by Application
2.5.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
3 RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET SIZE BY PLAYER
3.1 Respiratory Syncytial Virus Vaccines Market Size Market Share by Players
3.1.1 Global Respiratory Syncytial Virus Vaccines Revenue by Players (2018-2023)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RESPIRATORY SYNCYTIAL VIRUS VACCINES BY REGIONS
4.1 Respiratory Syncytial Virus Vaccines Market Size by Regions (2018-2023)
4.2 Americas Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.3 APAC Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.4 Europe Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
4.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023)
5.2 Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
5.3 Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023)
6.2 APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
6.3 APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Respiratory Syncytial Virus Vaccines by Country (2018-2023)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Respiratory Syncytial Virus Vaccines by Region (2018-2023)
8.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023)
8.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET FORECAST
10.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2024-2029)
10.1.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2024-2029)
10.1.2 Americas Respiratory Syncytial Virus Vaccines Forecast
10.1.3 APAC Respiratory Syncytial Virus Vaccines Forecast
10.1.4 Europe Respiratory Syncytial Virus Vaccines Forecast
10.1.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast
10.2 Americas Respiratory Syncytial Virus Vaccines Forecast by Country (2024-2029)
10.2.1 United States Respiratory Syncytial Virus Vaccines Market Forecast
10.2.2 Canada Respiratory Syncytial Virus Vaccines Market Forecast
10.2.3 Mexico Respiratory Syncytial Virus Vaccines Market Forecast
10.2.4 Brazil Respiratory Syncytial Virus Vaccines Market Forecast
10.3 APAC Respiratory Syncytial Virus Vaccines Forecast by Region (2024-2029)
10.3.1 China Respiratory Syncytial Virus Vaccines Market Forecast
10.3.2 Japan Respiratory Syncytial Virus Vaccines Market Forecast
10.3.3 Korea Respiratory Syncytial Virus Vaccines Market Forecast
10.3.4 Southeast Asia Respiratory Syncytial Virus Vaccines Market Forecast
10.3.5 India Respiratory Syncytial Virus Vaccines Market Forecast
10.3.6 Australia Respiratory Syncytial Virus Vaccines Market Forecast
10.4 Europe Respiratory Syncytial Virus Vaccines Forecast by Country (2024-2029)
10.4.1 Germany Respiratory Syncytial Virus Vaccines Market Forecast
10.4.2 France Respiratory Syncytial Virus Vaccines Market Forecast
10.4.3 UK Respiratory Syncytial Virus Vaccines Market Forecast
10.4.4 Italy Respiratory Syncytial Virus Vaccines Market Forecast
10.4.5 Russia Respiratory Syncytial Virus Vaccines Market Forecast
10.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast by Region (2024-2029)
10.5.1 Egypt Respiratory Syncytial Virus Vaccines Market Forecast
10.5.2 South Africa Respiratory Syncytial Virus Vaccines Market Forecast
10.5.3 Israel Respiratory Syncytial Virus Vaccines Market Forecast
10.5.4 Turkey Respiratory Syncytial Virus Vaccines Market Forecast
10.5.5 GCC Countries Respiratory Syncytial Virus Vaccines Market Forecast
10.6 Global Respiratory Syncytial Virus Vaccines Forecast by Type (2024-2029)
10.7 Global Respiratory Syncytial Virus Vaccines Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Information
11.1.2 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Inc.Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc.Pfizer Inc. Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Respiratory Syncytial Virus Vaccines Product Offered
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Information
11.3.2 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Merck Sharp & Dohme Main Business Overview
11.3.5 Merck Sharp & Dohme Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 SOBI
11.5.1 SOBI Company Information
11.5.2 SOBI Respiratory Syncytial Virus Vaccines Product Offered
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 SOBI Main Business Overview
11.5.5 SOBI Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Information
11.7.2 Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bavarian Nordic Main Business Overview
11.7.5 Bavarian Nordic Latest Developments
11.8 Novavax
11.8.1 Novavax Company Information
11.8.2 Novavax Respiratory Syncytial Virus Vaccines Product Offered
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novavax Main Business Overview
11.8.5 Novavax Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Moderna
11.10.1 Moderna Company Information
11.10.2 Moderna Respiratory Syncytial Virus Vaccines Product Offered
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Moderna Main Business Overview
11.10.5 Moderna Latest Developments
11.11 Codagenix
11.11.1 Codagenix Company Information
11.11.2 Codagenix Respiratory Syncytial Virus Vaccines Product Offered
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Codagenix Main Business Overview
11.11.5 Codagenix Latest Developments
11.12 Intravacc
11.12.1 Intravacc Company Information
11.12.2 Intravacc Respiratory Syncytial Virus Vaccines Product Offered
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Intravacc Main Business Overview
11.12.5 Intravacc Latest Developments
11.13 Alphavax
11.13.1 Alphavax Company Information
11.13.2 Alphavax Respiratory Syncytial Virus Vaccines Product Offered
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Alphavax Main Business Overview
11.13.5 Alphavax Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Respiratory Syncytial Virus Vaccines Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Palivizumab
Table 3. Major Players of RSVpreF PF06928316
Table 4. Major Players of RSVPreF3 OA (GSK3844766A)
Table 5. Major Players of mRNA-1345
Table 6. Major Players of Janssen RSV Vaccine
Table 7. Major Players of ResVax
Table 8. Major Players of Nirsevimab (MEDI8897)
Table 9. Major Players of MVA-BN RSV
Table 10. Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 13. Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 16. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player (2018-2023)
Table 18. Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
Table 19. Respiratory Syncytial Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Respiratory Syncytial Virus Vaccines Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2018-2023)
Table 24. Global Respiratory Syncytial Virus Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2018-2023)
Table 28. Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 30. Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 32. APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Table 34. APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 36. APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 38. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2018-2023)
Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 42. Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus Vaccines
Table 51. Key Market Challenges & Risks of Respiratory Syncytial Virus Vaccines
Table 52. Key Industry Trends of Respiratory Syncytial Virus Vaccines
Table 53. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Pfizer Inc.Pfizer Inc. Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 58. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
Table 59. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Pfizer Inc.Pfizer Inc. Main Business
Table 61. Pfizer Inc.Pfizer Inc. Latest Developments
Table 62. Sanofi Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 63. Sanofi Respiratory Syncytial Virus Vaccines Product Offered
Table 64. Sanofi Main Business
Table 65. Sanofi Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Sanofi Latest Developments
Table 67. Merck Sharp & Dohme Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 68. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
Table 69. Merck Sharp & Dohme Main Business
Table 70. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Sharp & Dohme Latest Developments
Table 72. GlaxoSmithKline Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 73. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
Table 74. GlaxoSmithKline Main Business
Table 75. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GlaxoSmithKline Latest Developments
Table 77. SOBI Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 78. SOBI Respiratory Syncytial Virus Vaccines Product Offered
Table 79. SOBI Main Business
Table 80. SOBI Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. SOBI Latest Developments
Table 82. Johnson & Johnson Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 83. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Johnson & Johnson Latest Developments
Table 87. Bavarian Nordic Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 88. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
Table 89. Bavarian Nordic Main Business
Table 90. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Bavarian Nordic Latest Developments
Table 92. Novavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 93. Novavax Respiratory Syncytial Virus Vaccines Product Offered
Table 94. Novavax Main Business
Table 95. Novavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Novavax Latest Developments
Table 97. AstraZeneca Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 98. AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Latest Developments
Table 102. Moderna Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 103. Moderna Respiratory Syncytial Virus Vaccines Product Offered
Table 104. Moderna Main Business
Table 105. Moderna Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Moderna Latest Developments
Table 107. Codagenix Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 108. Codagenix Respiratory Syncytial Virus Vaccines Product Offered
Table 109. Codagenix Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Codagenix Main Business
Table 111. Codagenix Latest Developments
Table 112. Intravacc Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 113. Intravacc Respiratory Syncytial Virus Vaccines Product Offered
Table 114. Intravacc Main Business
Table 115. Intravacc Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Intravacc Latest Developments
Table 117. Alphavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 118. Alphavax Respiratory Syncytial Virus Vaccines Product Offered
Table 119. Alphavax Main Business
Table 120. Alphavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Alphavax Latest Developments
Table 1. Respiratory Syncytial Virus Vaccines Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Palivizumab
Table 3. Major Players of RSVpreF PF06928316
Table 4. Major Players of RSVPreF3 OA (GSK3844766A)
Table 5. Major Players of mRNA-1345
Table 6. Major Players of Janssen RSV Vaccine
Table 7. Major Players of ResVax
Table 8. Major Players of Nirsevimab (MEDI8897)
Table 9. Major Players of MVA-BN RSV
Table 10. Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 13. Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 16. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player (2018-2023)
Table 18. Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
Table 19. Respiratory Syncytial Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Respiratory Syncytial Virus Vaccines Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2018-2023)
Table 24. Global Respiratory Syncytial Virus Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2018-2023)
Table 28. Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 30. Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 32. APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Table 34. APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 36. APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 38. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2018-2023)
Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 42. Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus Vaccines
Table 51. Key Market Challenges & Risks of Respiratory Syncytial Virus Vaccines
Table 52. Key Industry Trends of Respiratory Syncytial Virus Vaccines
Table 53. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Pfizer Inc.Pfizer Inc. Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 58. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
Table 59. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Pfizer Inc.Pfizer Inc. Main Business
Table 61. Pfizer Inc.Pfizer Inc. Latest Developments
Table 62. Sanofi Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 63. Sanofi Respiratory Syncytial Virus Vaccines Product Offered
Table 64. Sanofi Main Business
Table 65. Sanofi Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Sanofi Latest Developments
Table 67. Merck Sharp & Dohme Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 68. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
Table 69. Merck Sharp & Dohme Main Business
Table 70. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Sharp & Dohme Latest Developments
Table 72. GlaxoSmithKline Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 73. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
Table 74. GlaxoSmithKline Main Business
Table 75. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. GlaxoSmithKline Latest Developments
Table 77. SOBI Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 78. SOBI Respiratory Syncytial Virus Vaccines Product Offered
Table 79. SOBI Main Business
Table 80. SOBI Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. SOBI Latest Developments
Table 82. Johnson & Johnson Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 83. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Johnson & Johnson Latest Developments
Table 87. Bavarian Nordic Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 88. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
Table 89. Bavarian Nordic Main Business
Table 90. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Bavarian Nordic Latest Developments
Table 92. Novavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 93. Novavax Respiratory Syncytial Virus Vaccines Product Offered
Table 94. Novavax Main Business
Table 95. Novavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Novavax Latest Developments
Table 97. AstraZeneca Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 98. AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Latest Developments
Table 102. Moderna Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 103. Moderna Respiratory Syncytial Virus Vaccines Product Offered
Table 104. Moderna Main Business
Table 105. Moderna Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Moderna Latest Developments
Table 107. Codagenix Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 108. Codagenix Respiratory Syncytial Virus Vaccines Product Offered
Table 109. Codagenix Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Codagenix Main Business
Table 111. Codagenix Latest Developments
Table 112. Intravacc Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 113. Intravacc Respiratory Syncytial Virus Vaccines Product Offered
Table 114. Intravacc Main Business
Table 115. Intravacc Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Intravacc Latest Developments
Table 117. Alphavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 118. Alphavax Respiratory Syncytial Virus Vaccines Product Offered
Table 119. Alphavax Main Business
Table 120. Alphavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Alphavax Latest Developments
LIST OF FIGURES
Figure 1. Respiratory Syncytial Virus Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Respiratory Syncytial Virus Vaccines Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Respiratory Syncytial Virus Vaccines Sales Market Share by Country/Region (2022)
Figure 8. Respiratory Syncytial Virus Vaccines Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2022
Figure 10. Respiratory Syncytial Virus Vaccines in Hospital
Figure 11. Global Respiratory Syncytial Virus Vaccines Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Respiratory Syncytial Virus Vaccines in Clinic
Figure 13. Global Respiratory Syncytial Virus Vaccines Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Respiratory Syncytial Virus Vaccines in Research Institute
Figure 15. Global Respiratory Syncytial Virus Vaccines Market: Research Institute (2018-2023) & ($ Millions)
Figure 16. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2022
Figure 17. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player in 2022
Figure 18. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 20. APAC Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 21. Europe Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 23. Americas Respiratory Syncytial Virus Vaccines Value Market Share by Country in 2022
Figure 24. United States Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region in 2022
Figure 29. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2022
Figure 30. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2022
Figure 31. China Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country in 2022
Figure 38. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Figure 39. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Figure 40. Germany Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 54. APAC Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 55. Europe Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 57. United States Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 58. Canada Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 61. China Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 62. Japan Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 63. Korea Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 65. India Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 66. Australia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 67. Germany Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 68. France Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 69. UK Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 70. Italy Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 71. Russia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 72. Spain Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 75. Israel Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 78. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Respiratory Syncytial Virus Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Respiratory Syncytial Virus Vaccines Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Respiratory Syncytial Virus Vaccines Sales Market Share by Country/Region (2022)
Figure 8. Respiratory Syncytial Virus Vaccines Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2022
Figure 10. Respiratory Syncytial Virus Vaccines in Hospital
Figure 11. Global Respiratory Syncytial Virus Vaccines Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Respiratory Syncytial Virus Vaccines in Clinic
Figure 13. Global Respiratory Syncytial Virus Vaccines Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Respiratory Syncytial Virus Vaccines in Research Institute
Figure 15. Global Respiratory Syncytial Virus Vaccines Market: Research Institute (2018-2023) & ($ Millions)
Figure 16. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2022
Figure 17. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player in 2022
Figure 18. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 20. APAC Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 21. Europe Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2018-2023 ($ Millions)
Figure 23. Americas Respiratory Syncytial Virus Vaccines Value Market Share by Country in 2022
Figure 24. United States Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region in 2022
Figure 29. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2022
Figure 30. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2022
Figure 31. China Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country in 2022
Figure 38. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Figure 39. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Figure 40. Germany Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Respiratory Syncytial Virus Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 54. APAC Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 55. Europe Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 57. United States Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 58. Canada Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 61. China Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 62. Japan Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 63. Korea Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 65. India Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 66. Australia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 67. Germany Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 68. France Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 69. UK Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 70. Italy Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 71. Russia Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 72. Spain Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 75. Israel Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Respiratory Syncytial Virus Vaccines Market Size 2024-2029 ($ Millions)
Figure 78. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Application (2024-2029)
